Department of Health and Human Services
Centers for Disease Control and Prevention
 |
||||||||||||||||
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
Centers for DiseaseControl and Prevention Division of Cancer Prevention and Control 4770 Buford Hwy, NE MS K-64 Atlanta, GA 30341-3717 Call: 1 (800) CDC-INFO TTY: 1 (888) 232-6348 FAX: (770) 488-4760 E-mail: cdcinfo@cdc.gov Submit a Question Online |
|
|
|
Arctic Slope Native
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Women Served through the NBCCEDP Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Women served* | 1,335 |
| Women screened** | 1,335 |
| Women receiving mammography | 598 |
| Women receiving Pap tests | 1,137 |
|
Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category. * Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure. ** Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test). Data Source: April 2008 submission of NBCCEDP Minimum Data Elements (MDE) |
|
|
Distribution by Race/Ethnicity Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited  Women receiving an NBCCEDP-funded Pap test = 1,137 |
|
Distribution by Age Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited  Women receiving an NBCCEDP-funded Pap test = 1,137 |
| See text description of these graphs. |
|
Cervical Cancer Screening Results and Outcomes Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Pap tests provided | 2,168 |
| Pap tests with abnormal results* | 47 |
| Percentage of Pap tests with abnormal results | 2.2 |
| Age-adjusted percentage** | 1.5 |
| Cervical cancers or cancer precursor lesions detected*** | ^ |
| CIN-1 or LSIL | ^ |
| CIN-2 or worse**** | ^ |
| Rate of CIN-2 or worse detected per 1,000 Pap tests**** | ^ |
| Age-adjusted rate per 1,000 Pap tests** | ^ |
|
* Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer. ** Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000. *** Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)-1, CIN-2, CIN-3, carcinoma in situ (CIS), and invasive cervical cancer. **** Includes HSIL, CIN-2, CIN-3, CIS, and invasive cervical cancer. Table includes only NBCCEDP-funded Pap tests. Additionally, less than 16 women, not included above, were diagnosed with LSIL, HSIL, CIN-1, CIN-2, CIN-3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source. ^ Data suppressed due to less than 16 records in numerator or denominator. |
|
|
Distribution by Race/Ethnicity Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited  Women receiving an NBCCEDP-funded mammogram = 598 |
|
Distribution by Age Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited  Women receiving an NBCCEDP-funded mammogram = 598 |
| See text description of these graphs. |
|
Breast Cancer Screening Results and Outcomes Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Mammograms provided | 1,117 |
| Abnormal mammograms* | 48 |
| Percentage of abnormal mammograms | 4.3 |
| Age-adjusted percentage** | 4.3 |
| Breast cancers detected*** | ^ |
| Rate of breast cancers detected per 1,000 mammograms | ^ |
| Age-adjusted rate per 1,000 mammograms** | ^ |
|
* Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete. ** Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000. *** Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS). Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. ^ Data suppressed due to less than 16 records in numerator or denominator. |
|
|
Distribution by Race/Ethnicity Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Race | Percentage |
| White | 2.6 |
| Black | 0.3 |
| Asian/Pacific Islander | 6.2 |
| American Indian/Alaska Native | 88.4 |
| Multiracial | 0.2 |
| Hispanic | 0.9 |
| Unknown | 1.6 |
| Women receiving an NBCCEDP-funded Pap test = 1,137 | |
| Distribution by Age Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Age | Percentage |
| <30 | 42.0 |
| 30–39 | 18.7 |
| 40–49 | 23.0 |
| 50–64 | 14.7 |
| 65+ | 1.6 |
| Unknown | 0.0 |
| Women receiving an NBCCEDP-funded Pap test = 1,137 | |
Return to the Cervical Cancer Screening section
| Distribution by Race/Ethnicity Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Race | Percentage |
| White | 5.2 |
| Black | 0.2 |
| Asian/Pacific Islander | 10.7 |
| American Indian/Alaska Native | 82.3 |
| Multiracial | 0.2 |
| Hispanic | 0.8 |
| Unknown | 0.7 |
| Women receiving an NBCCEDP-funded mammogram = 598 | |
| Distribution by Age Five-Year Summary, 7/2002 to 6/2007 Arctic Slope Native Association Limited |
|
|---|---|
| Age | Percentage |
| <40 | 4.2 |
| 40–49 | 54.3 |
| 50–64 | 37.8 |
| 65+ | 3.7 |
| Unknown | 0.0 |
| Women receiving an NBCCEDP-funded mammogram = 598 | |
Return to the Breast Cancer Screening section
|
|
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
